InvestorsHub Logo
Followers 72
Posts 6896
Boards Moderated 0
Alias Born 12/07/2011

Re: TheHound post# 64132

Wednesday, 07/30/2014 10:03:23 PM

Wednesday, July 30, 2014 10:03:23 PM

Post# of 403509
DF runs the show. How hard is that for you to understand?

Quote:
To date, six cohorts have completed enrollment, with the sixth cohort receiving infusions at 110 mg/m2. Maximum Tolerated Dose (“MTD”) has still not been reached. To date, one patient has competed 7 dosing cycles; 2 patients have completed 5 dosing cycles; 1 patient has completed 4 dosing cycles; 1 patient has completed 3 dosing cycles; 8 patients have completed 2 dosing cycles; and 7 patients have completed 1 dosing cycle. A dosing cycle is 28 days. - See more at: cellceutix.com/cellceutix-provides-updates-on-clinical-trials-and-developments-of-its-anti-cancer-anti-psoriasis-and-antibiotic-compounds/#sthash.Pg8Dzfgh.dpuf


Is that not enough data for you?

So you want a prelim report DURING a phase 1? LOL


How about the fact they gave us p21 data in the first cohorts and it was positive. At 35 mg/m2 or less!?!? Now we are over 200mg/m2!!!

I don't understand what you think you deserve?
JUST FYI....this is not about investments. It's about a breakthrough in medical history.... That can help mankind.....


Good luck!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News